Catalysts for Horizon Therapeutics USA Inc
11 tracked
Dec 11, 2025
approval
UPLIZNA (INEBILIZUMAB-CDON) — FDA approval
Horizon Therapeutics USA Inc
→
Nov 24, 2025
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Sep 9, 2025
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Aug 26, 2025
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Apr 3, 2025
approval
UPLIZNA (INEBILIZUMAB-CDON) — FDA approval
Horizon Therapeutics USA Inc
→
Jul 17, 2023
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Apr 13, 2023
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Dec 6, 2022
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Oct 26, 2021
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Jun 11, 2020
approval
UPLIZNA (INEBILIZUMAB-CDON) — FDA approval
Horizon Therapeutics USA Inc
→
Jan 21, 2020
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→